Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00218270 · ClinicalTrials.gov registry record · Phase 2

Effectiveness of Using Tobacco Free Snuff in Reducing Negative Effects of Smokeless Tobacco Use

A Phase 2 study of Tobacco Use Disorder, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
Phase 2
Development phase
138
Enrollment target
1
Study location

NCT00218270 is a Phase 2 study of Tobacco Use Disorder that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 138 participants, below the 237-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00218270, a Phase 2 study of Tobacco Use Disorder, has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
Phase 2
Development phase
138 participants
Enrollment target
1
Study location

Study Summary

Though spit tobacco is smokeless, it still affects the cardiovascular system and may be associated with heart disease, stroke, and high blood pressure. Long-term effects of smokeless tobacco (ST) include tooth abrasion, gum recession, mouth disease, loss of bone in the jaw, yellowing of teeth, and chronic bad breath. This study will assess the effectiveness of using tobacco free snuff in reducing levels of exposure to tobacco and associated toxicity, as well as enhancing motivation to either quit or sustain lower levels of nicotine intake.

Conditions Studied

Tobacco Use Disorder

Interventions

  • DRUG Tobacco free snuff

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 138 participants
Start Date 2002-12
Est. Completion 2005-05
Phase Phase 2

Sponsor

National Institute on Drug Abuse (NIDA)

335 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00218270

The ClinicalTrials.gov registry entry for NCT00218270 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 237-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (42% lower). The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Tobacco free snuff is the first listed.

NCT00218270 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT00218270 about?

NCT00218270 is a clinical study titled "Effectiveness of Using Tobacco Free Snuff in Reducing Negative Effects of Smokeless Tobacco Use". Though spit tobacco is smokeless, it still affects the cardiovascular system and may be associated with heart disease, stroke, and high blood pressure. Long-term effects of smokeless tobacco (ST) include tooth abrasion, gum recession, mouth disease, loss of bone in the jaw, yellowing of teeth, and c...

What is the current status of trial NCT00218270?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 138 participants. The study started on 2002-12. Estimated completion is 2005-05.

What conditions does trial NCT00218270 study?

This clinical trial studies the following conditions: Tobacco Use Disorder.

What interventions are being tested in trial NCT00218270?

The interventions under investigation include: Tobacco free snuff (DRUG).

Who is sponsoring clinical trial NCT00218270?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00218270 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Tobacco Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Tobacco Use Disorder

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.